Trisomy 6 as a Primary Karyotypic Aberration in Hematologic Disorders

Anwar N. Mohamed(City Of Hope National Medical Center), Marilyn L. Slovak(City Of Hope National Medical Center), Mary Varterasian(Phenomenome Discoveries (Canada)), Cheryl L. Willman(Mayo Clinic), David R. Head(University of Southern California), Sandra R. Wolman(Wayne State University), Cathryn Rankin(Cleveland Clinic), Thomas S. McConnell, Sheila M. Dobin(Baylor Scott & White Medical Center - Temple)
Cancer Genetics and Cytogenetics
October 1, 1998
10.1016/s0165-4608(98)00057-0
Cited by 28

Related Papers

Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k
Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study
|Blood|2000|1.6k
Deletion of <i>IKZF1</i> and Prognosis in Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2009|1.4k
Age and acute myeloid leukemia
|Blood|2006|1.4k
All-<i>trans</i>-Retinoic Acid in Acute Promyelocytic Leukemia
|New England Journal of Medicine|1997|1.1k